Merck's Gardasil Not Cleared for Older Women

Greg Owen

Attorney

0 CommentsPrint ArticleSubscribe

At this time the cervical cancer vaccine known as Gardasil will not be approved for older women. That is the word to Merck & Co from the U.S. regulators.

Merck was seeking approval to extend the availability of the drug to women between the ages of 27 and 45. However, the U.S. Food and Drug Administration (FDA) has stated that there are ‘issues’ that are a road block to the requested approval.

Gardasil is used to protect against more strains of the Human Papillomavirus that causes cervical cancer and genital warts in females between the ages of 9-26. This lack of clearance is clearly a disappointment to Merck. Gardasil was one of the company’s more successful products.

Additional Information Pertaining to Defective and Dangerous Products